Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-18-005524
Filing Date
2018-07-06
Accepted
2018-07-06 08:01:51
Documents
5
Period of Report
2018-08-14
Effectiveness Date
2018-07-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a.htm DEF 14A 867702
2 GRAPHIC def14ag001.jpg GRAPHIC 52241
3 GRAPHIC def14ag002.jpg GRAPHIC 4136
4 GRAPHIC def14ag003.gif GRAPHIC 57500
5 GRAPHIC def14ag004.gif GRAPHIC 40230
  Complete submission text file 0001558370-18-005524.txt   1081271
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

EIN.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: DEF 14A | Act: 34 | File No.: 001-37411 | Film No.: 18941754
SIC: 2834 Pharmaceutical Preparations